1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
2MARCELLILN P, CHANG TT, LIM SG, et al. Adefovir dipivnxil for the treatment of hepatitis Be antigen-positive chronic hepatitis B [J]. NEngl J Med, 2003, 348(9): 808-816. 被引量：1
3MACELLIN P, CHANG TT, LIM S, et al. Long term efficacy and safety of adefovir dipivoxil 10 mg in HBeAg^* chronic hepatitis B patients: increasing serologic, virologic and biochemical response over time[J]. Hepatology, 2004, 40 (Suppl 4) : 655A. 被引量：1
8Daly AK,Donaldson PT.HLA-B*5701genotype is a major deter-minant of drug-induced liver injury due to flucloxacillin[J].Nat Genet,2009,41(7):816-819. 被引量：1
9Kumar R,Shalimar.Antituberculosis therapy-induced acute liver failure:magnitude and predictors of outcome[J].Hepatology,2010,51(5):1665-1674. 被引量：1
10Lucena MI,Molokhia M.Susceptibility to amoxicillin–clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles[J].Gastroenterology,2011,141(1):338–347. 被引量：1
